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OBJECTIVES: Families in the neurologic ICU urgently request goals-of-
care decision support and shared decision-making tools. We recently de-
veloped a goals-of-care decision aid for surrogates of critically ill traumatic 
brain injury patients using a systematic development process adherent to the 
International Patient Decision Aid Standards. To widen its applicability, we 
adapted this decision aid to critically ill patients with intracerebral hemorrhage 
and large hemispheric acute ischemic stroke. 
DESIGN: Prospective observational study.
SETTING: Two academic neurologic ICUs.
SUBJECTS: Twenty family members of patients in the neurologic ICU 
were recruited from July 2018 to October 2018.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS:  We reviewed the existing crit-
ically ill traumatic brain injury patients decision aid for content and changed: 
1) the essential background information, 2) disease-specific terminology to 
“hemorrhagic stroke” and “ischemic stroke”, and 3) disease-specific prog-
nosis tailored to individual patients. We conducted acceptability and usability 
testing using validated scales. All three decision aids contain information from 
validated, disease-specific outcome prediction models, as recommended by 
international decision aid standards, including careful emphasis on their un-
certainty. We replaced the individualizable icon arrays graphically depicting 
probabilities of a traumatic brain injury patient’s prognosis with icon arrays 
visualizing intracerebral hemorrhage and hemispheric acute ischemic stroke 
prognostic probabilities using high-quality disease-specific data. We selected 
the Intracerebral Hemorrhage Score with validated 12-month outcomes, and 
for hemispheric acute ischemic stroke, the 12-month outcomes from landmark 
hemicraniectomy trials. Twenty family members participated in acceptability 
and usability testing (n = 11 for the intracerebral hemorrhage decision aid; n = 
9 for the acute ischemic stroke decision aid). Median usage time was 22 min-
utes (interquartile range, 16–26 min). Usability was excellent (median System 
Usability Scale = 84/100 [interquartile range, 61–93; with > 68 indicating 
good usability]); 89% of participants graded the decision aid content as good 
or excellent, and greater than or equal to 90% rated it favorably for information 
amount, balance, and comprehensibility.
CONCLUSIONS: We successfully adapted goals-of-care decision aids 
for use in surrogates of critically ill patients with intracerebral hemorrhage 
and hemispheric acute ischemic stroke and found excellent usability and 
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acceptability. A feasibility trial using these decision 
aids is currently ongoing to further validate their ac-
ceptability and test their feasibility for use in busy 
neurologic ICUs.
KEY WORDS: critical care; intracerebral 
hemorrhage; palliative medicine; prognosis; shared 
decision-making; stroke 
Shared decision-making is a collaborative approach that encourages clinicians, patients, and surro-gates to work together to make treatment decisions 
based on the best available scientific evidence, while 
also considering the patient’s values, goals, and prefer-
ences (1). The Institute of Medicine and major critical 
care societies have strongly recommended that clini-
cians incorporate shared decision-making in the ICU 
(1, 2). Although shared decision-making has been suc-
cessfully implemented for many health decisions (3), 
empiric research in medical-surgical ICUs has shown 
that only 2% of ICU clinician-family communica-
tions meet all recommended criteria for shared deci-
sion-making (4). Our previous research in surrogates 
and physicians in the neurologic ICU (neuroICU) has 
identified an urgent but unmet need for goals-of-care de-
cision support and shared decision-making tools (deci-
sion aids [DAs]) (5). The sudden and unexpected nature 
of catastrophic neurologic diseases adds greatly to the 
surrogates’ burden of making the morally difficult life-
or-death goals-of-care decision on behalf of these criti-
cally ill and incapacitated patients. This large emotional 
burden on families, combined with existing deficiencies 
in clinician-family communication in the ICU, results 
in poorly informed treatment decisions, high rates of 
psychologic distress in families, and high utilization of 
expensive, burdensome treatments which may be misa-
ligned with patients’ values and preferences (4, 6, 7).
To narrow this gap, we developed a paper-based pilot 
DA for surrogates of critically ill traumatic brain injury 
(ciTBI) patients making goals-of-care decisions using 
a rigorous and systematic approach (8). Importantly, 
this DA meets International Patient DA Quality 
Standards (8, 9), which is an international guide on the 
content of high-quality DAs. During the DA’s devel-
opment process, we received input from stakeholders, 
both surrogates and physicians, that goals-of-care DAs 
for other neurologic emergencies are urgently needed.
Intracerebral hemorrhage (ICH) and large hemi-
spheric acute ischemic stroke (AIS) are the fifth leading 
cause of death in the United States (10, 11), and most 
of the deaths related to both of these diseases are due to 
withdrawal of life-sustaining treatments in ICUs (12). 
Currently, no DAs exist for surrogates of critically ill 
ICH and AIS patients. One other DA for strokes of 
all severities has recently been developed, which offers 
a web-based tool for both noncritically ill and criti-
cally ill patients making life-sustaining treatment 
decisions (13). Our DA is different from this tool in 
several ways: our tool purposefully includes 10 real 
photographs supplementing text, depicts the esti-
mated prognosis in three levels (rather than 5) using 
icon arrays (rather than pie charts), all with the inten-
tion to lower the cognitive burden on stressed surro-
gates of critically ill patients (8, 13).
The objective of our current study was to adapt 
our existing goals-of-care DA for surrogates of ciTBI 
patients to critically ill patients with ICH and large 
hemispheric AIS, measure usage time, usability and 
acceptability, and obtain qualitative feedback. These 
important steps are standard and necessary in the DA 
development process prior to deploying the DAs in the 
neuroICU for feasibility.
MATERIALS AND METHODS
This study was conducted at two academic medical cen-
ters: the University of Massachusetts Medical School/
UMass Memorial Medical Center and Yale New Haven 
Hospital. The University of Massachusetts Institutional 
Review Board (IRB protocol number H00015764) and the 
Yale University Institutional Review Board (IRB protocol 
number 2000023655) granted approval for this study and 
allowed participants to be enrolled through verbal con-
sent due to the minimal risk posed by the study.
Goals-of-Care DA for Surrogates of ciTBI 
Patients
The rigorous, stepwise development process for our 
goals-of-care DA for surrogates of ciTBI patients, 
which meets International Patient DA Quality Standards 
criteria for high-quality DAs (9), has been previously pub-
lished (8). In brief, this traumatic brain injury (TBI) goals-
of-care DA is paper based, written at a sixth grade reading 
level, printed on 12 double-sided pages in Times New 
Roman font in letter size 16, and contains 10 photographs 
and several tables. The ciTBI DA includes the following 
information: TBI terminology and essential background 
Observational Study
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information; the nature of the goals-of-care decision; treat-
ment options; potential post-ICU discharge dispositions 
or withdrawal of life-sustaining treatments with comfort-
based care; an individualized icon array displaying each 
patient’s unique estimated prognosis derived from the 
validated TBI International Mission for Prognosis and 
Analysis of Clinical Trials model, accompanied by text 
carefully explaining and emphasizing prognostic uncer-
tainty associated with prediction models; two patient 
examples; and an one-page worksheet designed to pre-
pare surrogates for the family meeting (including a values 
clarification exercise, decision-readiness assessment, and 
a tear-away page to record questions) (Supplemental 
Fig. 1, Supplemental Digital Content 1, http://links.lww.
com/CCX/A517) (8).
Adaptation of ciTBI DA to ICH and AIS
To adapt our existing goals-of-care DA for patients 
with ciTBI to those with an ICH and hemispheric AIS, 
we first changed the essential background information 
and disease-specific terminology about TBI to ICH 
and AIS, using terminology of “hemorrhagic stroke” 
and “ischemic stroke.” We anticipated that additional 
changes to the terminology would be required based 
on family user feedback, which we were planning to 
obtain as part of the adaptation process.
Per the International Patient DA Quality Standards, 
all DAs should include data derived from validated 
outcome prediction models that carefully visualize po-
tential outcomes and describe uncertainties (9). In ac-
cordance with these standards, and based on our prior 
qualitative work with neuroICU surrogates showing 
that estimated prognosis was a strongly desired com-
ponent (14), we chose to include an individualized 
prognosis estimated by a validated prediction model, 
similar to the ciTBI DA. Of note, we also chose to 
provide accompanying text to clearly explain and em-
phasize prognostic uncertainty (Supplemental Fig. 2, 
Supplemental Digital Content 2, http://links.lww.com/
CCX/A518), due to our awareness of the potential 
pitfalls of predicting an individual patient’s prognosis 
using prediction models derived from broad popula-
tions (8). In all of our DAs, explicit text informs sur-
rogates that the prediction model does not take into 
account their loved one’s medical history, injuries to 
other organs, clinical course, and complications in the 
ICU and that they should ask the doctor how these fac-
tors may change their loved one’s prognosis.
Two board-certified neurointensivists (D.Y.H., 
S.M.) reviewed the current literature and carefully 
weighed advantages and disadvantages of existing 
models, while also considering patients’ and fami-
lies’ desire for information on longer term outcomes. 
After considerable discussion, for the ICH model, we 
selected the previously validated 12-month functional 
outcomes associated with the original ICH score, 
given the ICH score’s widespread use and the value of 
its 12-month follow-up data (15). We contacted the 
senior author who shared the raw and deidentified 
12-month functional outcome data using the modi-
fied Rankin Score for each ICH score for the purpose 
of our DA adaptation. With similar reasoning, after 
reviewing 23 different AIS prognostication models 
(16), we selected the most robust, high-level data, 
which stem from the large hemicraniectomy trials. We 
selected the 12-month outcome data available from 
the published hemicraniectomy trials Decompressive 
Craniectomy In Malignant Middle Cerebral Artery 
Infarcts, Decompressive Surgery for the Treatment of 
Malignant Infarction of the Middle Cerebral Artery 
(DESTINY), Hemicraniectomy After Middle Cerebral 
Artery Infarction With Life-Threatening Edema Trial 
(17), and DESTINY II (18).
We created icon arrays that can be individualized 
to the patient using the patient’s clinical variables. For 
ICH, we created six different icon arrays based on the 
ICH score ranging from 0 to 5. Of note, we did not 
create an icon array for the most severe ICH score of 
6, since no patient received this score in the 12-month 
validation study (15), likely due to the fact that an ICH 
score of 6 is both rare and severe, such that patients 
did not survive to 12 months post ICH. It is also highly 
unlikely that a DA would be used for a patient with 
an ICH score of 6 due to the severity of the disease 
and nearly certain ultimate outcome. For hemispheric 
AIS, we created four different icon arrays, differenti-
ating between patients less than or equal to 60 years 
or greater than 60 years, as well as those who did or 
did not undergo hemicraniectomy. For both ICH and 
hemispheric AIS, we dichotomized favorable and un-
favorable modified Rankin Scale outcomes as less than 
or equal to 4 and greater than 4.
Acceptability and Usability Testing
Participants. Participants were recruited from both 
neuroICU waiting rooms using the following inclusion 
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criteria: age greater than or equal to 18 years, family 
member or friend of a patient admitted to the neuroICU 
with any disease, willing to read the DA with a study 
staff member present; English-speaking, and willing to 
spend approximately 45 minutes with study staff to pro-
vide verbal feedback and undergo usability and accept-
ability testing using validated scales (19, 20). We used a 
purposive sampling strategy to recruit surrogates who 
were either actively engaged in the process of support-
ing their family member in the neuroICU environment, 
including decision-making for their family member, 
but did not require surrogates to specifically be making 
decisions for TBI or stroke patients, given that the focus 
of feedback was on ease of navigation and use.
Trained members of the study team approached and 
recruited family members or friends of patients admit-
ted to the neuroICU with a neurologic illness using an 
IRB-approved verbal consent script and printed fact 
sheet. After verbal consent was obtained, a member 
of the study team brought the participant to a private 
room near the neuroICU waiting room. The partici-
pant was provided with a hypothetical scenario about 
a patient with an ICH or hemispheric AIS awaiting a 
goals-of-care decision. Participants received the DA as 
a spiral-bound, color-printed booklet for either ICH or 
hemispheric AIS on an alternating schedule. The only 
instructions provided by the study team member were 
when to start reading the DA and to also complete the 
worksheet at the end of the DA.
Covariates Collected. The study team member 
observed and timed the participant while they read 
through the DA, noting any signs of struggle or confu-
sion, either nonverbal or verbal. We collected data on 
the age, gender, and study center of the participants.
Assessment Scales. Following the reading of the 
DA and worksheet, the participant completed a short, 
written questionnaire assessing usability and accept-
ability of the DA using validated scales. We used the 
industry standard for assessing usability, the System 
Usability Scale (SUS), which is a 10-item, five-point 
Likert-scale with scores ranging from 0 to 100 (19). A 
SUS greater than or equal to 68 is an accepted cut-off 
for “good usability” (19). Our target SUS for “excellent 
usability” was greater than 80 (21). The Acceptability 
Scale is comprised of an nine-item, four-point Likert-
scale that assesses DA content and seven additional 
questions assessing acceptability of length, information 
amount, balance of information, usefulness of the DA, 
understanding of prognosis, the personal worksheet, 
and completeness of information for decision-making. 
Two open-ended questions ask what participants liked 
about the DA and worksheet and any suggestions to im-
prove both items (20). As in our previously published 
DA derivation study, we conservatively targeted greater 
than 70% for “good acceptability,” as our review of the 
literature did not reveal a validated or accepted cut-off 
for what constituted “good” acceptability (8). Both scales 
are validated and considered the industry’s standard in 
DA research. Finally, a short verbal feedback session was 
elicited by a member of the study staff.
Statistical Analysis. Standard descriptive statistics 
were applied to calculate median usage times, SUS and 
Acceptability Scale scores, as well as proportions for re-
sponse options. For the Acceptability Scale, we calcu-
lated the composite proportions for each Likert-scale 
point (“excellent,” “good,” “fair,” or “poor”) for the nine 
content questions. For each of the seven additional ac-
ceptability questions, we dichotomized the responses 
as “favorable” or “unfavorable.” We qualitatively ana-
lyzed the verbal feedback and grouped responses by 
positive comments about the DAs and suggestions 
for improvement. We recruited a purposive sample of 
20 participants. This number was based on what was 
pragmatically feasible and on studies that show that 
80% of usability problems can be identified with as few 
as 10 participants, whereas 95% of usability problems 
can be identified with 20 participants (22).
RESULTS
Over a 4-month period (July 2018 to October 2018), 
20 participants completed acceptability and usability at 
both centers; 11 participants received the ICH DA, and 
nine received the hemispheric AIS DA. Of the partici-
pants, 15 (75%) were female, and the mean participant 
age was 55 (± 15) years. Median time to read the DA 
was 22 minutes (interquartile range [IQR], 16–26 min). 
Participants rated the usability of both DAs as “excellent” 
with a median SUS score of 84 of 100 (IQR, 61–93) with 
a SUS greater than 68 indicating good usability (19) (Fig. 
1). Most participants (89%) rated the acceptability of the 
DAs’ content as good (49.2%) or excellent (40.1%; mul-
ticolor bar in Fig. 1). Participants rated all other items 
on the Acceptability Scale favorably (length [85%], infor-
mation amount [80%], balance [90%], usefulness [95%], 
prognosis [85%], worksheet [95%], and enough informa-
tion to make a decision [85%]) (light blue bars in Fig. 1). 
Observational Study
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The individual responses of the Acceptability Scale are 
provided in Supplementary Table 1 (Supplemental 
Digital Content 3, http://links.lww.com/CCX/A519).
Verbal feedback from participants was largely pos-
itive and acknowledged that both DAs would be very 
helpful for families making goals-of-care decisions 
on behalf of their loved ones (Table  1). Several sug-
gestions to improve the DAs were made, including 
using more lay terms for “intracerebral hemorrhage” 
and “acute ischemic stroke.” Based on this feedback, 
we changed the disease names in the titles of DAs to 
“Bleeding Stroke” and “Stroke,” respectively.
DISCUSSION
We adapted a novel goals-of-care DA for surrogates 
of ciTBI patients for use in surrogates of critically 
ill patients with ICH and large hemispheric AIS by 
incorporating validated, disease-specific, 12-month 
outcome prediction data to communicate probabili-
ties of long-term outcome, including the uncertainties 
pertaining to the outcome. The DAs meet international 
DA standards and were rated with very high accepta-
bility and usability by surrogates.
To our knowledge, these DAs are the first goals-of-
care DAs specifically for critically ill patients with ICH 
and large hemispheric AIS. There is only one other DA 
that has been developed for patients who have devel-
oped a stroke and their surrogates (13). However, our 
DAs differ from this recently published DA in sev-
eral ways: first, our DAs specifically target critically 
ill patients, rather than serving surrogates of stroke 
patients of all severities; second, our DAs contain 
12-month validated outcomes. Surrogate decision-
makers highly value long-term validated outcomes, 
which the authors of the other DA acknowledged as 
a limitation in their DA (13). The other DA uses an 
ordinal prognostication model predicting 90-day 
functional outcome, which the authors self-developed 
and derived from data from the Virtual International 
Stroke Trials Archive Plus (13). Third, our DA uses 
icon arrays to depict prognosis, in contrast to pie chart 
and horizontal stacked bars to allow portrayal of 5 or-
dinal levels of the modified Rankin Score, which could 
be overwhelming in users with lower numeracy skills; 
we have based our choice of icon arrays on research 
that has shown that icon arrays are best for risk com-
munication (24, 25) and on direct feedback from sur-
rogates (8). For our DA, we conducted acceptability 
testing in addition to the standard usability testing. 
Last, in contrast to the other web-based DA, our tool 
is paper based with many photographs, which may fa-
cilitate use among computer-illiterate surrogates (13).
One other medical/surgical ICU DA is available 
for patients with prolonged mechanical ventilation 
without a neurologic diagnosis, but a recent large clin-
ical trial of this DA produced neutral results for the 
primary outcome of surrogate-physician prognostic 
concordance and psychologic distress in families (26). 
Our DA is different from this DA, because it is aimed at 
surrogates of neurocritically ill patients with TBI, ICH, 
and large hemispheric AIS, who face much more com-
plex decision-making related to “both” the neurologic 
prognosis and the need for ventilation and artificial 
nutrition, and it includes a worksheet with values clari-
fication, which surrogates complete. The goal is for cli-
nicians to use this worksheet to guide the goals-of-care 
Figure 1. Acceptability and usability testing. Twenty participants 
completed usability and acceptability testing at UMass and Yale. 
Participants were recruited from the neuroICU waiting rooms at 
each center and completed testing using validated scales (19, 
20). The multicolor bar represents a composite of nine questions 
related to the acceptability of the content of the decision aids. 
Eighty-nine percent of participants rated the content as good or 
excellent (multicolor bar). The light blue bars represent favorable 
responses related to the acceptability of length (85%), information 
amount (80%), balance (90%), usefulness (95%), prognosis 
(85%), worksheet (95%), and enough information to make 
decision (85%). The individual responses for the Acceptability 
Scale can be found in Supplementary Table 1 (Supplemental 
Digital Content 3, http://links.lww.com/CCX/A519). The dark 
blue bar represents the System Usability Scale (SUS), the 
industry standard in measuring usability of a tool (19). Participants 
rated usability as excellent (median SUS = 84/100), where a 
SUS greater than 68 is considered good (23).
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discussion via a “facilitated deliberation” (27–30). We 
based this approach on expert recommendations (31), 
and results from two clinical trials suggested that a 
knowledge approach alone will not influence emotion-
ally laden life-support decisions, which are made intu-
itively using a “gut feeling” (26, 27, 32). However, our 
approach has not been tested in a clinical trial.
We understand that there is great risk in applying 
prediction models to individual patients. A gap analysis 
exploring prognostication in neurocritical care noted that 
current prognostic models are useful but limited (16). 
Some of the major gaps included lack of individual-
ized patient measures, such as failure to account for 
medical comorbidities, and not including in-hospital 
events and clinical complications (16). Another study 
comparing formal prediction models with clinician 
judgment when predicting 3-month functional out-
come (modified Rankin scale) in ICH patients found 
that clinicians judgment correlated more closely with 
actual patient outcome at 3 months (33). However, 
we included icon arrays with data derived from vali-
dated prediction models, because per the International 
Patient DA Quality Standards, high-quality DAs should 
present probabilities of potential outcomes (9) and be-
cause surrogates expressed a strong desire for it in our 
prior qualitative research and physicians felt it could 
ground other physicians given the existing variability 
in prognostication (14, 34–36). We mitigated the risk 
both by using validated models of high quality and by 
explicitly acknowledging the uncertainty around the 
projected outcome in each DA and stating that each 
patient has other, individual factors that influence out-
come, which are not contained in the model. We also 
advised surrogates to consult with their doctor and ask 
for “best case” and “worst case” scenarios.
Our study has a number of important strengths and 
limitations. Strengths include the systematic develop-
ment process with acceptability and usability testing and 
feedback from family member and surrogate stakehold-
ers from two different medical centers. Additionally, we 
ensured that our DAs meet international DA standards. 
Of note, there is considerable variability in DA research 
with regards to standards of acceptability and usability 
testing practices (37). Similar to our published ciTBI DA 
development process, we recruited general neuroICU 
surrogate decision-makers for our acceptability and 
TABLE 1. 
Qualitative Feedback by Acceptability and Usability Testing Participants on the Intracere-
bral Hemorrhage and Large Hemispheric Acute Ischemic Stroke Decision Aids
Participants Found the Decision Aid Helpful
Participants Made These Suggestions for 
Improvement
“I think it was very well done. I think people would find it 
very helpful. I think it is easy to understand. It’s heart 
wrenching, but it’s helpful.”
[I] “wished [there were more] footnotes [explaining] 
glossary terms, like what AIS means.”
“With my father, I couldn’t imagine how difficult it would 
be if I had to make a decision. I think this tool will make 
a big difference. I think it was really well put together. I 
think it was all well done.”
“[I] wish [there was] more information about the 
consequences to the family member - for example, 
the financial and emotional costs associated with 
each option.”
“I think this will be a really great thing for the families to 
see. It would be helpful to start thinking about what 
they will do before the meeting. I personally liked the 
icons. I see these types of images a lot in my work. I 
think it was clear.”
“In a digital version, there could be videos of, for 
example, someone on a ventilator, and that at certain 
points in the aid, the digital system could ask the 
reader ‘Did you understand ___? Yes/ No’ before 
allowing them to move on.”
“It’s a great survey, easy to read (especially for a layperson 
experiencing shock), well laid-out and explained, pretty 
spot-on, and easy to navigate. The aid could really help 
someone in that position to make a tough decision.”
 
We show representative quotes of the qualitative feedback by participants grouped by positive comments about the decision aids and 
suggestions for improvement. These were derived by either the participants providing written feedback as part of the open-ended 
questions of the Acceptability Scale or research staff eliciting verbal qualitative feedback and taking notes of the responses.
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usability testing convenience sample using a hypothet-
ical scenario and did not strictly limit the sample to only 
families of patients with an ICH or large hemispheric 
AIS in the midst of a real-time goals-of-care decision. 
Use of hypothetical scenarios has been a successful, prac-
tical approach in a number of prior research studies of 
ICU surrogates tasked with making high-acuity deci-
sions (38–40). The experiential realism of our hypothet-
ical scenario was enhanced by the fact that we did recruit 
all subjects for acceptability and usability directly from 
a neuroICU environment. We acknowledge that using 
population-based risked estimates to gauge an indi-
vidual patient’s prognosis is a limitation and that we can-
not completely eliminate that small risk of self-fulfilling 
prophecy; however, research has shown that surrogates 
desire outcome prognostication (14), and no DA is meant 
to stand alone without a clinician-family discussion. 
Additional potential limitations include that we did not 
collect race, ethnicity, or education level in our accepta-
bility and usability testing participants. Furthermore, we 
excluded non-English speakers since our DA has not yet 
been translated and validated in other languages.
CONCLUSIONS
We adapted our goals-of-care DA for surrogates of 
critically ill TBI patients to surrogates of critically ill 
patients with ICH and large hemispheric AIS. We cre-
ated two new DAs, which meet international DA stan-
dards, include disease-specific icon arrays to visualize 
individualized patient outcome probabilities, and have 
been rated highly by surrogate decision-makers for 
usability and acceptability. We are currently testing 
feasibility of DA implementation in a multicenter 
pilot trial.
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